Below are the most recent publications written about "Schizophrenic Psychology" by people in Profiles.
-
Herrera SN, Zemon V, Revheim N, Silipo G, Gordon J, Butler PD. Cognitive function mediates the relationship between visual contrast sensitivity and functional outcome in schizophrenia. J Psychiatr Res. 2021 12; 144:138-145.
-
Jerome RN, Pulley JM, Sathe NA, Krishnaswami S, Dickerson AB, Worley KJ, Wilkins CH. Exploring Biologic Predictors Response Disparities to Atypical Antipsychotics among Blacks: A Quasi-Systematic Review. Ethn Dis. 2020; 30(Suppl 1):229-240.
-
Hallford DJ, Sharma MK. Anticipatory pleasure for future experiences in schizophrenia spectrum disorders and major depression: A systematic review and meta-analysis. Br J Clin Psychol. 2019 Nov; 58(4):357-383.
-
Preda A, Nguyen DD, Bustillo JR, Belger A, O'Leary DS, McEwen S, Ling S, Faziola L, Mathalon DH, Ford JM, Potkin SG, van Erp TGM. A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDS. Schizophr Res. 2018 11; 201:113-119.
-
Warren KR, Wehring HJ, Liu F, McMahon RP, Chen S, Chester C, Kelly DL. Effects of intranasal oxytocin on satiety signaling in people with schizophrenia. Physiol Behav. 2018 05 15; 189:86-91.
-
van Erp TG, Preda A, Nguyen D, Faziola L, Turner J, Bustillo J, Belger A, Lim KO, McEwen S, Voyvodic J, Mathalon DH, Ford J, Potkin SG. Converting positive and negative symptom scores between PANSS and SAPS/SANS. Schizophr Res. 2014 Jan; 152(1):289-94.
-
Warren KR, Buchanan RW, Feldman S, Conley RR, Linthicum J, Ball MP, Liu F, McMahon RP, Gorelick DA, Huestis MA, Kelly DL. Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study. J Clin Psychopharmacol. 2013 Feb; 33(1):118-20.
-
Whaley AL. Psychiatric and demographic predictors of memory deficits in African Americans with schizophrenia: the moderating role of cultural mistrust. Psychiatr Q. 2012 Jun; 83(2):113-26.
-
Strauss GP, Wilbur RC, Warren KR, August SM, Gold JM. Anticipatory vs. consummatory pleasure: what is the nature of hedonic deficits in schizophrenia? Psychiatry Res. 2011 May 15; 187(1-2):36-41.
-
Kelly DL, Gorelick DA, Conley RR, Boggs DL, Linthicum J, Liu F, Feldman S, Ball MP, Wehring HJ, McMahon RP, Huestis MA, Heishman SJ, Warren KR, Buchanan RW. Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study. J Clin Psychopharmacol. 2011 Feb; 31(1):86-91.